Published in Gastrointest Endosc on February 01, 1976
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Clinical significance of hiatal hernia. Gut Liver (2011) 1.04
Oesophageal histology in reflux oesophagitis. J Clin Pathol (1985) 0.92
Properly conducted fundoplication reverses histologic evidence of esophagitis. Ann Surg (1983) 0.85
The yield of a continuously patent gastroesophageal junction during upper endoscopy as a predictor of esophagitis in children. Dig Dis Sci (2010) 0.76
Endoscopic measurement of oesophageal transmucosal potential difference in reflux oesophagitis. Gut (1984) 0.75
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol (1974) 5.89
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology (1993) 4.41
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Patterns of gastroesophageal reflux in health and disease. Ann Surg (1976) 4.07
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
Pneumatosis intestinalis: a review. Am J Gastroenterol (1995) 3.48
Regulation of histone mRNA production and stability in serum-stimulated mouse 3T6 fibroblasts. Mol Cell Biol (1983) 3.13
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Evaluation of current operations for the prevention of gastroesophageal reflux. Ann Surg (1974) 2.91
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med (1999) 2.77
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology (1992) 2.57
Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology (1994) 2.55
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology (1985) 2.44
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J Biol Chem (1980) 2.40
Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology (1992) 2.35
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus. Gastroenterology (1996) 2.23
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med (2001) 2.22
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol (1978) 2.13
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis (2009) 2.06
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
Cell cycle regulation of dihydrofolate reductase mRNA metabolism in mouse fibroblasts. Proc Natl Acad Sci U S A (1980) 2.02
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Regulation of ribosomal protein mRNA content and translation in growth-stimulated mouse fibroblasts. Mol Cell Biol (1982) 1.98
Minding your OTCs. Occup Health Saf (2001) 1.94
Cancer surveillance in ulcerative colitis. Gastroenterology (1991) 1.93
Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91
Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol (1985) 1.91
Management of esophageal perforation. Am J Surg (1980) 1.90
Oxytocin and neurohypophyseal peptides: spectral assignment and conformational analysis by 220 MHz nuclear magnetic resonance. Proc Natl Acad Sci U S A (1969) 1.87
Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1996) 1.82
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Regulation of dihydrofolate reductase gene expression in mouse fibroblasts during the transition from the resting to growing state. J Cell Physiol (1978) 1.80
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res (1996) 1.74
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Gastric cancer. Contemporary aspects. Am J Surg (1977) 1.72
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci (1983) 1.70
Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line. Mol Cell Biol (1985) 1.70
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Histologic correlates of gastrointestinal ultrasound images. Gastroenterology (1989) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
In vitro and in vivo analysis of the control of dihydrofolate reductase gene transcription in serum-stimulated mouse fibroblasts. J Cell Physiol (1984) 1.67
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology (1995) 1.65
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Myoepithelioma of minor salivary gland origin. Light and electron microscopical study. Arch Pathol (1975) 1.63
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61
Regulation of dihydrofolate reductase synthesis in an overproducing 3T6 cell line during transition from resting to growing state. Proc Natl Acad Sci U S A (1979) 1.61
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60
Changes in RNA in relation to growth of the fibroblast. III. Posttranscriptional regulation of mRNA formation in resting and growing cells. Cell (1975) 1.59
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology (1990) 1.59
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis (1999) 1.58
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55
Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54
Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res (1999) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52
Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. Exp Cell Res (1982) 1.52
Prognosis after colonic resection for Crohn's disease of the colon. Gastroenterology (1973) 1.51
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis (1996) 1.49
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg (1996) 1.49
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg (1985) 1.48
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48
Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48
Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery (1989) 1.44